Objective
iP-OSTEO project focuses on development of novel cell-based scaffolds for bone and cartilage repair in patients with poor regenerative capacity. We are proposing technology combining iPSCs with improved regeneration capacity combined with nanostructured scaffolds based on electrospun scaffolds and drug delivery system stimulating cell regeneration based on electrosprayed and spray-dried particles. The system will deliver novel treatment method for older patients, for which the current cellular and cell-free methods are ineffective.
iP-OSTEO will reach its goals by creating an international and interdisciplinary training program. 7 companies (SMEs) and 7 academic institutions across European Union will join there forces though dedicated secondments. The activities will involve networking, research/training, workshop and dissemination secondments. The project has in total 239 secondments involving exchange of Early-stage and Experienced researchers. The consortium is bonded by Dr. Eva Filova – young scientist with experience in bone and cartilage tissue engineering.
The iP-OSTEO project will help in better integration of academic and industrial stakeholders across Europe and help diseased people by providing novel therapeutic methods. Nevertheless, project has 169 ESR secondment months leading to training of new generation of scientists with international connection and knowledge of intrasectorial enviroment.
Field of science
- /medical and health sciences/medical biotechnology/cells technologies/stem cells
- /medical and health sciences/medical biotechnology/tissue engineering
Call for proposal
H2020-MSCA-RISE-2018
See other projects for this call
Funding Scheme
MSCA-RISE - Marie Skłodowska-Curie Research and Innovation Staff Exchange (RISE)Coordinator
14220 Praha 4
Czechia
Participants (13)
11000 Praha
9026 Gyor
10827 Berlin
2970 Hoersholm
3500 Krems An Der Donau
WC1E 6BT London
47533 Kleve
30419 Hannover
0349 Oslo
80686 Munchen
4200-135 Porto
3723 MB Bilthoven
02-106 Warsaw
